Cell and gene therapies are placing the patient at the center of the supply chain in a vastly new way, with implications for production, financial operations, product ordering, logistics and patient access and support. With these high-value therapies gaining more acclaim and moving from academic treatment centers to community care, their therapeutic and commercial success will be more highly scrutinized. In this webinar, commercial, patient access and clinical supply chain leaders will gain:

  • A step-by-step understanding of the cell and gene therapy patient and product journey
  • Insight into how to establish a seamlessly connected process between sites of care, patients, their healthcare providers and payers
  • Lessons from experts at the forefront of this new therapy paradigm
  • Practical advice on pivotal questions related to product ordering, patient hub design and payer considerations

Featured Speakers

J. Andrew Case

Head of Clinical Supply Chain – Individualized Therapies
Genentech

Andy focuses on building and expanding Clinical Supply Chain capabilities for an expanding portfolio of individualized therapies at Genentech/Roche. Prior to joining Genentech, Andy was the global business owner managing the Novartis business solution for the first to market CAR-T therapy. He is a subject matter expert in CAR-T Chain of Identity, order management, international supply chain solutions and technology development, enabling commercial launches in 28+ countries.

Amy DuRoss

Co-founder & CEO
Vineti

Before co-founding Vineti, Amy focused on healthcare new business creation for GE Ventures. Prior to GE, Amy was Chief Business Officer at Navigenics, a genomics company sold to Life Technologies in 2012. She was co-founder and Executive Director of Proposition 71, California’s $3B stem cell research initiative passed in 2004. Amy also serves as a member of the Board of Directors for the ARM Foundation for Cell and Gene Medicine.

Josh Marsh

Director, Access & Patient Support
Cardinal Health

Josh Marsh is responsible for oversight of hub operations at Sonexus™ Access & Patient Support. Helping ensure that patients can access therapy quickly, Josh’s team investigates patient benefits and offers education to patients on their coverage and financial obligations. In addition, his team helps with prior authorizations and appeals, while also identifying resources to help patients afford essential medicines. Before working in the hub space, he spent 13 years in retail pharmacy, specialty pharmacy, and pharmacy benefits management.

Marc Puich - Moderator 

Senior VP – Business Development
Vineti

Marc focuses on leading the global sales activities for the Vineti Platform. Prior to joining Vineti Marc, held various positions at Werum IT Solutions, the leading provider of Manufacturing Execution Systems for the Pharmaceutical Industry. There, he was directly involved with sales and implementation of Werum’s PAS-X MES, as well as supporting organizations as they continued to drive benefits post go-live. Marc came to Werum with ten years consulting experience focused on the pharmaceutical and biotech sectors at Tefen USA.

NOW AVAILABLE ON-DEMAND

Register now for this webinar